Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
Brunangelo Falini, Giovanni Martino, Stefano Lazzi
Leukemia (2022) Vol. 37, Iss. 1, pp. 18-34
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Risk and prognosis of post-transplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - An observational cohort study from Norway and western Denmark
Lene Ugilt Pagter Ludvigsen, Anders Åsberg, Signe Spetalen, et al.
American Journal of Transplantation (2025)
Open Access | Times Cited: 1
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 34, pp. 4071-4083
Closed Access | Times Cited: 7
Artificial Intelligence Analysis and Reverse Engineering of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using Gene Expression Data
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 295-320
Open Access | Times Cited: 5
Post-Transplant Lymphoproliferative Disorders (Review for Seminars in Nephrology)
Vikas R. Dharnidharka, Marianna B. Ruzinova, Lianna J. Marks
Seminars in Nephrology (2024) Vol. 44, Iss. 1, pp. 151503-151503
Closed Access | Times Cited: 5
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review
Fabien Claves, Sylvain Carras, Barbara Burroni, et al.
eJHaem (2024) Vol. 5, Iss. 1, pp. 242-246
Open Access | Times Cited: 4
Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
A. E. C. Schirren, John D. Albrecht, Susanne Melchers, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 954-966
Open Access | Times Cited: 4
Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
Shams ElDoha Galal ElDin Zaiema, Heba Mohamed Saber Hafez, Diaa El-Din Moussa Sherif Abou El-Ela, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Flow-optimized microfluidic chip for improved immunohistochemistry analysis
Yijie Zhou, Qiuxiang Yu, Ping Dong, et al.
Microfluidics and Nanofluidics (2025) Vol. 29, Iss. 4
Closed Access
Diagnostic Implications of NGS-Based Molecular Profiling in Mature B-Cell Lymphomas with Potential Bone Marrow Involvement
Bernhard Strasser, Sebastian Mustafa, Josef Seier, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 727-727
Open Access
Primary Cutaneous T-Cell Lymphoid Neoplasms
Robert Gniadecki, Minakshi Taparia, Jean Deschênes, et al.
(2025), pp. 45-47
Closed Access
Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
Aisling M. Ross, Ciara I. Leahy, Fiona Neylon, et al.
Life (2023) Vol. 13, Iss. 2, pp. 521-521
Open Access | Times Cited: 11
A comparison of the International Consensus and 5th WHO classifications of T‐cell lymphomas and histiocytic/dendritic cell tumours
Brunangelo Falini, Stefano Lazzi, Stefano Pileri
British Journal of Haematology (2023) Vol. 203, Iss. 3, pp. 369-383
Open Access | Times Cited: 7
TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
Siyue Lou, Fanli Zheng, Yongmei Tang, et al.
Life Sciences (2024) Vol. 347, pp. 122662-122662
Closed Access | Times Cited: 2
New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications
Kennosuke Karube, Akira Satou, Seiichi Kato
International Journal of Hematology (2024)
Closed Access | Times Cited: 2
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma
Anu Singh, Jagruti Patil, Sitaram Ghogale, et al.
Cytometry Part B Clinical Cytometry (2024) Vol. 106, Iss. 5, pp. 359-369
Open Access | Times Cited: 2
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
Abdurraouf Mokhtar Mahmoud, Gianluca Gaïdano, Samir Mouhssine
Cancers (2023) Vol. 15, Iss. 4, pp. 1015-1015
Open Access | Times Cited: 5
Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials
Tadeusz Robak, Paweł Robak
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 311-324
Closed Access | Times Cited: 5
Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma
Maria‐Myrsini Tzioni, Alexandra Clipson, Zi Chen, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 7, pp. 1003-1007
Closed Access | Times Cited: 1
Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: A Single-Centre Experience
Bálint Virga, László Imre Pinczés, Árpád Illés, et al.
Cureus (2024)
Open Access | Times Cited: 1
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis
Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, et al.
Blood (2024) Vol. 144, Iss. 19, pp. 2063-2066
Closed Access | Times Cited: 1
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies
Paweł Robak, Magdalena Witkowska, Anna Wolska, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 10, pp. 1065-1076
Closed Access | Times Cited: 4
Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway
G. Gao, Qingfeng Xue, Jing He, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111125-111125
Open Access | Times Cited: 4
LYMPHOPROLIFERATIVE DISORDERS

(2024), pp. 357-506
Closed Access | Times Cited: 1
ICC‐2022 versus WHO‐2022 classification systems for acute leukemias and myeloid neoplasms: The perspective from two classical morphologists
Gina Zini, John M. Bennett
American Journal of Hematology (2023) Vol. 98, Iss. 8
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top